Robert H Dworkin
Overview
Explore the profile of Robert H Dworkin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
262
Citations
15199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Nishtar M, Mark R, Langford D, McDermott M, Markman J, Evans S, et al.
Reg Anesth Pain Med
. 2023 Nov;
49(5):363-367.
PMID: 37963675
Background: Randomized clinical trials (RCTs) generally assess efficacy and safety separately, with the conclusion of whether a treatment is beneficial based solely on the efficacy endpoint. However, assessing and combining...
12.
Michelson D, Chin W, Dworkin R, Freeman R, Herrmann D, Mazitschek R, et al.
Pain Rep
. 2023 Oct;
8(6):e1114.
PMID: 37899940
Introduction: Current treatments for painful diabetic peripheral neuropathy (DPN) are insufficiently effective for many individuals and do not treat nonpain signs and symptoms. The enzyme histone deacetylase type 6 (HDAC6)...
13.
Linguiti S, Vogel J, Sydnor V, Pines A, Wellman N, Basbaum A, et al.
Neurosci Biobehav Rev
. 2023 Oct;
154:105421.
PMID: 37802267
Functional magnetic resonance imaging (fMRI) is increasingly used to non-invasively study the acute impact of psychedelics on the human brain. While fMRI is a promising tool for measuring brain function...
14.
Dworkin R, McDermott M, Nayak S, Strain E
Clin Pharmacol Ther
. 2023 Oct;
114(6):1166-1169.
PMID: 37795632
No abstract available.
15.
Langford D, Sharma S, McDermott M, Beeram A, Besherat S, France F, et al.
J Pain
. 2023 Jun;
24(9):1555-1569.
PMID: 37327942
Self-reported pain intensity, frequently used as an outcome in randomized clinical trials (RCTs) of chronic pain, is often highly variable and could be associated with multiple baseline factors. Thus, the...
16.
What should be the entry pain intensity criteria for chronic pain clinical trials? An IMMPACT update
Langford D, Baron R, Edwards R, Gewandter J, Gilron I, Griffin R, et al.
Pain
. 2023 Jun;
164(9):1927-1930.
PMID: 37288944
No abstract available.
17.
Nayak S, Bradley M, Kleykamp B, Strain E, Dworkin R, Johnson M
J Clin Psychiatry
. 2023 May;
84(3).
PMID: 37167563
To systematically review control conditions of all available randomized psychedelic trials. We searched PubMed, PsycINFO, and EMBASE for randomized trials of psychedelics in humans from 1940 through May 2020 with...
18.
Faber C, Attal N, Lauria G, Dworkin R, Freeman R, Dawson K, et al.
EClinicalMedicine
. 2023 May;
59:101971.
PMID: 37152360
Background: No pharmacological treatments are specifically indicated for painful small fibre neuropathy (SFN). CONVEY, a phase 2 enriched-enrolment study, evaluated the efficacy and safety of vixotrigine, a voltage- and use-dependent...
19.
Zia F, Baumann M, Belouin S, Dworkin R, Ghauri M, Hendricks P, et al.
Neuropharmacology
. 2023 Apr;
233:109528.
PMID: 37015315
Chronic pain is a leading cause of disability, reduced productivity, healthcare seeking behavior, and a contributor to opioid overdose in the United States. For many people, pain can be satisfactorily...
20.
Hohenschurz-Schmidt D, Cherkin D, Rice A, Dworkin R, Turk D, McDermott M, et al.
Pain
. 2023 Mar;
164(7):1457-1472.
PMID: 36943273
Many questions regarding the clinical management of people experiencing pain and related health policy decision-making may best be answered by pragmatic controlled trials. To generate clinically relevant and widely applicable...